β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175

Identification of c- MYC as a Target of the APC Pathway

He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566

β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601

Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

Harvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056

Pathological prognostic factors in breast cancer

Elston, C. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00034-7 · Cited by 1,735

Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype

Sarrió, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G., & Palacios, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2017 · Cited by 1,056

Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.

Sparks, A. B., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · PubMed · Cited by 1,008

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

Hennessy, B. T., Gonzalez-Angulo, A.-M., Stemke-Hale, K., Gilcrease, M. Z., Krishnamurthy, S., Lee, J.-S., Fridlyand, J., Sahin, A., Agarwal, R., Joy, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3441 · Cited by 874

β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression

Lin, S.-Y., Xia, W., Wang, J. C., Kwong, K. Y., Spohn, B., Wen, Y., Pestell, R. G., & Hung, M.-C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060025397 · Cited by 783

Refinement of breast cancer classification by molecular characterization of histological special types

Weigelt, B., Horlings, H., Kreike, B., Hayes, M., Hauptmann, M., Wessels, L., de Jong, D., Van de Vijver, M., Veer, L. V., & Peterse, J. (2008) · The Journal of Pathology · doi:10.1002/path.2407 · Cited by 562

Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome

Khramtsov, A. I., Khramtsova, G. F., Tretiakova, M., Huo, D., Olopade, O. I., & Goss, K. H. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091125 · Cited by 509

Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors

Lazar, A. J. F., Tuvin, D., Hajibashi, S., Habeeb, S., Bolshakov, S., Mayordomo-Aranda, E., Warneke, C. L., Lopez-Terrada, D., Pollock, R. E., & Lev, D. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080475 · Cited by 455

Breast Cancer Staging: Working With the Sixth Edition of the AJCC Cancer Staging Manual

Singletary, S. E., & Connolly, J. L. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.1.37 · Cited by 391

β-catenin interacts with and inhibits NF-κB in human colon and breast cancer

Deng, J., Miller, S. A., Wang, H.-Y., Xia, W., Wen, Y., Zhou, B. P., Li, Y., Lin, S.-Y., & Hung, M.-C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00154-x · Cited by 372

Metaplastic breast carcinomas are basal‐like tumours

Reis‐Filho, J. S., Milanezi, F., Steele, D., Savage, K., Simpson, P. T., Nesland, J. M., Pereira, E. M., Lakhani, S. R., & Schmitt, F. C. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02467.x · Cited by 341

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

Tan, D. S. P., Marchió, C., Jones, R. L., Savage, K., Smith, I. E., Dowsett, M., & Reis-Filho, J. S. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9756-8 · Cited by 318

Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial–mesenchymal transition

Lien, H. C., Hsiao, Y. H., Lin, Y. S., Yao, Y. T., Juan, H. F., Kuo, W. H., Hung, M.-C., Chang, K. J., & Hsieh, F. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210593 · Cited by 225

Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis

Weigelt, B., Kreike, B., & Reis-Filho, J. S. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0197-9 · Cited by 224

β-Catenin and Tcfs in Mammary Development and Cancer

Hatsell, S., Rowlands, T., Hiremath, M., & Cowin, P. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025944723047 · Cited by 209

Re-expression of E-cadherin, ?-catenin and ?-catenin, but not of ?-catenin, in metastatic tissue from breast cancer patients

Bukholm, I. K., Nesland, J. M., & B�rresen-Dale, A.-L. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200001)190:1<15::aid-path489>3.0.co;2-l · Cited by 208

Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis

Savage, K., Lambros, M. B. K., Robertson, D., Jones, R. L., Jones, C., Mackay, A., James, M., Hornick, J. L., Pereira, E. M., Milanezi, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1371 · Cited by 206

E-cadherin and α-, β-, and γ-catenin protein expression in relation to metastasis in human breast carcinoma

Bukholm, I. K., Nesland, J. M., Kåresen, R., Jacobsen, U., & Børresen‐Dale, A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<262::aid-path97>3.0.co;2-y · Cited by 188

Quantitative In situ Analysis of β-Catenin Expression in Breast Cancer Shows Decreased Expression Is Associated with Poor Outcome

Dolled-Filhart, M., McCabe, A., Giltnane, J., Cregger, M., Camp, R. L., & Rimm, D. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0100 · Cited by 180

Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the Breast

Hayes, M. J., Thomas, D., Emmons, A., Giordano, T. J., & Kleer, C. G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4379 · Cited by 173

Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers

Natrajan, R., Lambros, M. B., Rodríguez-Pinilla, S. M., Moreno-Bueno, G., Tan, D. S. P., Marchió, C., Vatcheva, R., Rayter, S., Mahler-Araujo, B., Fulford, L. G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1878 · Cited by 170

Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis

Reis-Filho, J. S., Savage, K., Lambros, M. B. K., James, M., Steele, D., Jones, R. L., & Dowsett, M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800621 · Cited by 163

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

Marchiò, C., Iravani, M., Natrajan, R., Lambros, M., Savage, K., Tamber, N., Fenwick, K., Mackay, A. G., Senetta, R., Palma, S. D., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2368 · Cited by 161

Fibromatosis of the breast and mutations involving the APC/β-catenin pathway

Abraham, S. C., Reynolds, C., Lee, J.-H., Montgomery, E. A., Baisden, B. L., Krasinskas, A. M., & Wu, T.-T. (2002) · Human Pathology · doi:10.1053/hupa.2002.30196 · Cited by 161

Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis.

Miyaki, M., Konishi, M., Kikuchi‐Yanoshita, R., et al. (1993) · PubMed · Cited by 155

An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers

Natrajan, R., Weigelt, B., Mackay, A. G., Geyer, F. C., Grigoriadis, A. E., Tan, D. S. P., Jones, C., Lord, C. J., Vatcheva, R., Rodríguez-Pinilla, S. M., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0501-3 · Cited by 153

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

Arriola, E., Marchiò, C., Tan, D. S. P., Drury, S., Lambros, M. B. K., Natrajan, R., Rodríguez-Pinilla, S. M., Mackay, A. G., Tamber, N., Fenwick, K., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.19 · Cited by 151

Cytoplasmic Localization of β-Catenin is a Marker of Poor Outcome in Breast Cancer Patients

López‐Knowles, E., Zardawi, S. J., McNeil, C. M., Millar, E. K. A., Crea, P., Musgrove, E. A., Sutherland, R. L., & O'Toole, S. A. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0741 · Cited by 150

Expression of frizzled‐related protein and Wnt‐signalling molecules in invasive human breast tumours

Wong, S. C. C., Lo, S. F. E., Lee, K. C., Yam, J. W. P., Chan, J. K. C., & Hsiao, W. L. W. (2001) · The Journal of Pathology · doi:10.1002/path.1035 · Cited by 149

β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast

Lacroix‐Triki, M., Geyer, F. C., Lambros, M. B. K., Savage, K., Ellis, I. O., Lee, A. H. S., & Reis-Filho, J. S. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.141 · Cited by 136

Most Basal-like Breast Carcinomas Demonstrate the Same Rb−/p16+ Immunophenotype as the HPV-related Poorly Differentiated Squamous Cell Carcinomas Which They Resemble Morphologically

Subhawong, A. P., Subhawong, T. K., Nassar, H., Kouprina, N., Begum, S., VANG, R. S., Westra, W. H., & Argani, P. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31817f9790 · Cited by 111

Wnt signaling in hepatocellular carcinoma: Analysis of mutation and expression of beta‐catenin, T‐cell factor‐4 and glycogen synthase kinase 3‐beta genes

Cui, J., Zhou, X., Liu, Y., Tang, Z., & Romeih, M. H. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02973.x · Cited by 107

No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas.

Candidus, S., Bischoff, P., Becker, K., & Höfler, H. (1996) · PubMed · Cited by 106

Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype

Mahler-Araujo, B. M., Savage, K., Parry, S., & Reis-Filho, J. S. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.053991 · Cited by 101

Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast

Gillett, C., Miles, D. W., Ryder, K., Skilton, D., Liebman, R., Springall, R. J., Barnes, D. M., & Hanby, A. M. (2001) · The Journal of Pathology · doi:10.1002/path.831 · Cited by 95

Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies

Pedersen, K. B., Nesland, J. M., Fodstad, Ø., & Mælandsmo, G. M. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600624 · Cited by 83

Patho-biological aspects of basal-like breast cancer

Rakha, E. A., El‐Sayed, M. E., Reis-Filho, J. S., & Ellis, I. O. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9952-1 · Cited by 83

β‐Catenin and p53 analyses of a breast carcinoma tissue microarray

Chung, G. G., Zerkowski, M. P., Ocal, I. T., Dolled-Filhart, M. P., Kang, J. J., Psyrri, A. K., Camp, R. L., & Rimm, D. L. (2004) · Cancer · doi:10.1002/cncr.20232 · Cited by 72

PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study

Lambros, M. B. K., Natrajan, R., Geyer, F. C., López‐García, M. Á., Dedes, K. J., Savage, K., Lacroix‐Triki, M., Jones, R. L., Lord, C. J., Linardopoulos, S., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.121 · Cited by 71

APC and the three-hit hypothesis

Segditsas, S., Rowan, A., Howarth, K. M., Jones, A., Leedham, S. J., Wright, N. A., Gorman, P. A., Chambers, W. M., Domingo, E., Roylance, R. R., et al. (2008) · Oncogene · doi:10.1038/onc.2008.361 · Cited by 69

Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis

Savage, K., Leung, S. C. Y., Todd, S. K., Brown, L. A., Jones, R. L., Robertson, D. M., James, M., Parry, S., Pinilla, S. M. R., Huntsman, D. D., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9718-1 · Cited by 68

Target disruption of the mutant β-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype

Sekine, S., Shibata, T., Sakamoto, M., & Hirohashi, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205756 · Cited by 44

Nuclear β‐catenin expression and Wnt signalling: in defence of the dogma

Fodde, R., & Tomlinson, I. P. M. (2010) · The Journal of Pathology · doi:10.1002/path.2718 · Cited by 43

Wnt signaling in cancer

Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626

Wnt signaling in cancer.

Polakis, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008052 · Cited by 847

Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974

Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 831

Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy

Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01563-4 · Cited by 382

The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer

King, T. D., Suto, M. J., & Li, Y. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23350 · Cited by 296